Definium Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights
Go back to Definium Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights| (NASDAQ: DFTX) | Delayed: 37.09 +0.42 (1.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.67 | 52 Week High | $ | |||
| Open | $36.42 | 52 Week Low | $ | |||
| Day High | $37.72 | P/E | N/A | |||
| Day Low | $35.25 | EPS | $ | |||
| Volume | 1,636,708 | |||||

